8QQ
vs
LONN
8QQ
LONN
Over the past 12 months, 8QQ has outperformed LONN, delivering a return of -12% compared to the LONN's 15% drop.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
8QQ
LONN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Abcellera Biologics Inc
F:8QQ
|
2.696
EUR
|
|||||
|
Lonza Group AG
SIX:LONN
|
515
CHF
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
8QQ, LONN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Abcellera Biologics Inc
Revenue
|
|||||||||||
|
Lonza Group AG
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
8QQ, LONN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Abcellera Biologics Inc
F:8QQ
|
|||||||||
|
Lonza Group AG
SIX:LONN
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Abcellera Biologics Inc | ||||
|
Lonza Group AG | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
8QQ, LONN
Performance By Year
8QQ, LONN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.